Cadila may tap Chines market with new combo drug for TB
The 800 crore major Cadila Pharma has introduced world's first boosted Rifampicin combo-drug for the TB patients under the brand name of 'Risorine' which can bring down the cost of TB treatment by 33%.
Cadila launches new drug for TB treatment
Cadila Pharmaceuticals Ltd, an Ahmedabad based pharma major, on saturday launched Risorine, a drug for treatment of tuberculosis.
Cadila Pharma eyes Rs.80 crore from Risorine
Aims to enter China, Russia and African countries
Cadila eyes Rs.100 cr sales from anti-TB drugs in 2 years
Co launches anti-TB drug 'Risorine'
July 10, 2009
Clinical trials on Swine Flu vaccine soon.
Novavax Joins Hands with Cadila to begins tests in september, Drug to be commercially available y 2012
Cadila pharma, Novavax form Rs100 Crore JV co
To develop vaccine for Swine Flu, other Diseases
Cadila pharma ties up with Novavax for vaccine devpt
Will set up a 80:20 joint venture with an investment of around Rs100 Cr...
View the CPL archive with reprints or
links to past magazine articles....
'Polycap' hailed as 'wonder drug'; Cadila Pharmaceuticals is in global spotlight.
Nirma University recognizes Clinical Research and Pharmacology Centre (CRO) for Ph.D.
